AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
Amgen (NASDAQ: AMGN) has announced its participation in Citi's 2025 Virtual Oncology Leadership Summit scheduled for Wednesday, February 19, 2025, at 3:00 p.m. ET. Jean-Charles Soria, senior vice president of oncology within global development at Amgen, will represent the company at the conference.
The presentation will be accessible through a live webcast simultaneously available to investors, news media, and the general public. The webcast can be accessed through Amgen's website (www.amgen.com) under the Investors section, along with other management presentations from investor and medical conferences. The presentation will remain archived and available for replay on the website for a minimum of 90 days following the event.
Amgen (NASDAQ: AMGN) ha annunciato la sua partecipazione al Vertice Virtuale di Leadership Oncologica 2025 di Citi, programmato per mercoledì 19 febbraio 2025, alle 15:00 ET. Jean-Charles Soria, vicepresidente senior dell'oncologia nello sviluppo globale di Amgen, rappresenterà l'azienda alla conferenza.
La presentazione sarà accessibile tramite un webcast dal vivo disponibile contemporaneamente per investitori, media e pubblico generale. Il webcast sarà accessibile attraverso il sito web di Amgen (www.amgen.com) nella sezione Investitori, insieme ad altre presentazioni della direzione provenienti da conferenze per investitori e mediche. La presentazione rimarrà archiviata e disponibile per la visione on-demand sul sito per un minimo di 90 giorni dopo l'evento.
Amgen (NASDAQ: AMGN) ha anunciado su participación en el Simposio Virtual de Liderazgo en Oncología 2025 de Citi, programado para el miércoles 19 de febrero de 2025, a las 3:00 p.m. ET. Jean-Charles Soria, vicepresidente senior de oncología en el desarrollo global de Amgen, representará a la compañía en la conferencia.
La presentación será accesible a través de un webcast en vivo disponible simultáneamente para inversores, medios de comunicación y el público en general. El webcast se podrá acceder a través del sitio web de Amgen (www.amgen.com) en la sección de Inversores, junto con otras presentaciones de la dirección de conferencias para inversores y médicas. La presentación permanecerá archivada y disponible para su reproducción en el sitio durante un mínimo de 90 días después del evento.
Amgen (NASDAQ: AMGN)은 2025년 2월 19일 수요일 오후 3시 ET에 예정된 Citi의 2025년 가상 종양학 리더십 서밋에 참여한다고 발표했습니다. 장-샤를 소리아는 Amgen의 글로벌 개발 내 종양학 부문 수석 부사장으로서 회의에서 회사를 대표할 것입니다.
발표는 투자자, 언론 및 일반 대중이 동시에 접근할 수 있는 실시간 웹캐스트를 통해 제공됩니다. 웹캐스트는 Amgen의 웹사이트(www.amgen.com) 내 투자자 섹션에서 다른 투자자 및 의료 회의의 경영진 발표와 함께 접근할 수 있습니다. 발표는 이벤트 이후 최소 90일 동안 웹사이트에서 아카이브되어 재생할 수 있습니다.
Amgen (NASDAQ: AMGN) a annoncé sa participation au Sommet Virtuel de Leadership en Oncologie 2025 de Citi, prévu pour le mercredi 19 février 2025, à 15h00 ET. Jean-Charles Soria, vice-président senior de l'oncologie au sein du développement mondial chez Amgen, représentera l'entreprise lors de la conférence.
La présentation sera accessible via un webcast en direct disponible simultanément pour les investisseurs, les médias et le grand public. Le webcast pourra être consulté sur le site Web d'Amgen (www.amgen.com) dans la section Investisseurs, ainsi que d'autres présentations de la direction lors de conférences pour investisseurs et médicales. La présentation restera archivée et disponible en replay sur le site pendant au moins 90 jours après l'événement.
Amgen (NASDAQ: AMGN) hat seine Teilnahme am Citi's 2025 Virtuellen Onkologie-Leitungsgipfel angekündigt, der für Mittwoch, den 19. Februar 2025, um 15:00 Uhr ET geplant ist. Jean-Charles Soria, Senior Vice President für Onkologie in der globalen Entwicklung bei Amgen, wird das Unternehmen auf der Konferenz vertreten.
Die Präsentation wird über ein Live-Webcast zugänglich sein, der gleichzeitig für Investoren, Medien und die breite Öffentlichkeit verfügbar ist. Der Webcast kann über die Website von Amgen (www.amgen.com) im Bereich Investoren aufgerufen werden, zusammen mit anderen Management-Präsentationen von Investoren- und medizinischen Konferenzen. Die Präsentation wird mindestens 90 Tage nach der Veranstaltung archiviert und auf der Website zur Verfügung stehen.
- None.
- None.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, YouTube and Threads.
CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2025-virtual-oncology-leadership-summit-302377151.html
SOURCE Amgen
FAQ
When is Amgen (AMGN) presenting at Citi's 2025 Virtual Oncology Leadership Summit?
Who will represent AMGN at the Citi's 2025 Virtual Oncology Summit?
How can investors access AMGN's presentation at the 2025 Citi Oncology Summit?
How long will AMGN's 2025 Citi Oncology Summit presentation be available for replay?
